William Lis

2012 - Portola Pharmaceuticals

In 2012, William Lis earned a total compensation of $1.9M as Chief Executive Officer at Portola Pharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$121,500
Option Awards$1,392,329
Salary$405,000
Other$500
Total$1,919,329

Lis received $1.4M in option awards, accounting for 73% of the total pay in 2012.

Lis also received $121.5K in non-equity incentive plan, $405K in salary and $500 in other compensation.

Rankings

In 2012, William Lis' compensation ranked 3,703rd out of 11,487 executives tracked by ExecPay. In other words, Lis earned more than 67.8% of executives.

ClassificationRankingPercentile
All
3,703
out of 11,487
68th
Division
Manufacturing
1,277
out of 4,253
70th
Major group
Chemicals And Allied Products
286
out of 1,198
76th
Industry group
Drugs
166
out of 920
82nd
Industry
Pharmaceutical Preparations
129
out of 700
82nd
Source: SEC filing on April 30, 2015.

Lis' colleagues

We found two more compensation records of executives who worked with William Lis at Portola Pharmaceuticals in 2012.

2012

John Curnutte

Portola Pharmaceuticals

Executive Vice President, Research and Development

2012

Mardi Dier

Portola Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like